Novanta Inc. Common Stock (NOVT) fair value

ACCE thesis

Novanta makes precision photonics and motion components, including laser scanning modules, galvo and motion control systems, and medical-grade sensors, sold largely into OEM medical device and industrial laser customers. Its edge is embedding in customer platforms, where its components are specified early and then stay in production for years, which supports the 44.5% gross margin. Revenue growth of 10.3% is the number to test, since it depends on medical and industrial laser volumes recovering and on the company converting that growth into operating leverage; the 11.5% operating margin says it has not yet done so. The valuation is the interesting tension: a trailing P/E of 85.3 sits against a forward P/E of 8.4, which means earnings are expected to step up sharply, and that gap is the first thing to verify. With a 5.1B market cap, no index membership and a 5.1% ROE, the name is under-followed and the bull case rests on margin delivery rather than a narrative.